Drug lifts barrier for immunotherapy to fight rare liver cancer
February 17, 2026
February 17, 2026
ITHACA, New York, Feb. 17 -- Cornell University posted the following news:
* * *
Drug lifts barrier for immunotherapy to fight rare liver cancer
*
Immunotherapy - which activates the body's own immune system to kill cancer cells - has not worked well against a rare and fatal liver cancer, but a new study finds an existing FDA-approved drug may allow the immunotherapy to fight the cancer as intended, opening the door to a potential treatmen . . .
* * *
Drug lifts barrier for immunotherapy to fight rare liver cancer
*
Immunotherapy - which activates the body's own immune system to kill cancer cells - has not worked well against a rare and fatal liver cancer, but a new study finds an existing FDA-approved drug may allow the immunotherapy to fight the cancer as intended, opening the door to a potential treatmen . . .